Secondary Logo

Journal Logo

Advanced Search
ARTICLE

A Novel Susceptibility Locus Near GRIK2 Associated With Erosive Esophagitis in a Korean Cohort

Jin, Eun Hyo MD, PhD1; Park, Boram MPH2; Kim, Young Sun MD, PhD1; Choe, Eun Kyung MD, PhD3; Choi, Seung Ho MD, PhD1; Kim, Joo Sung MD, PhD1,4; Jung, Sung-Ae MD, PhD5

Author Information

1Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea;

2Department of Public Health Sciences, Seoul National University, Seoul, Korea;

3Department of Surgery, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea;

4Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea;

5Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.

Correspondence: Sung-Ae Jung, MD, PhD. E-mail: [email protected].

SUPPLEMENTARY MATERIAL accompanies this paper at https://links.lww.com/CTG/A220, https://links.lww.com/CTG/A221

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Clinical and Translational Gastroenterology: March 2020 - Volume 11 - Issue 3 - p e00145
doi: 10.14309/ctg.0000000000000145

Abstract

INTRODUCTION

Gastroesophageal reflux disease (GERD) develops when the reflux of gastric contents causes symptoms, such as heartburn and acid regurgitation (1,2). GERD symptoms are not perfectly correlated with endoscopic findings, however, with less than 50% of symptomatic patients showing signs of esophageal damage (1,3). According to endoscopic findings, cases with GERD can be classified into erosive esophagitis and nonerosive reflux disease (NERD) (4). Erosive esophagitis, or reflux esophagitis, is defined as an endoscopically proven esophageal mucosal injury above the gastroesophageal junction. Erosive esophagitis with chronic esophageal injury can result in Barrett's esophagus (BE), the replacement of normal squamous epithelium with specific columnar epithelium in the lower esophagus, leading to intestinal metaplasia (5). Although not all mechanisms of esophageal adenocarcinoma (EAC) have been identified, it is generally accepted that there is a sequential progression from erosive esophagitis to BE and finally to EAC (6).

Although no sex differences have been observed in the overall prevalence of GERD, erosive esophagitis is more common in men, whereas NERD is more common in women (7,8). In addition, BE and EAC are more frequently diagnosed in men, in an extension of pathological GERD (5,9). Because of the biological and physiological differences between men and women, sex affects the susceptibility, progression, and response to treatment for many diseases. It is also believed that men may be at a higher risk of pathogenesis and disease progression of erosive esophagitis (2,10,11).

Previous family and twin studies suggested a genetic influence on GERD development (12,13). Recently, many genome-wide association studies (GWAS) have made an effort to elucidate the genetic architecture of the disease. A recent GWAS identified a shared genetic background between GERD and BE and EAC (14). Some studies have identified several loci associated with the development of BE and EAC (15–17). However, no genome-wide significant single-nucleotide polymorphism (SNP) has been found for GERD. Although it is known that erosive esophagitis is more associated with esophageal structure, BE, and EAC than NERD, there has not yet been a GWAS study for the endoscopically diagnosed erosive esophagitis (1).

The conventional GWAS approach is a systematic search of SNPs across the genome to identify a novel genetic variation and find disease-related genes. Recently, several GWAS were conducted stratified by sex because of the reported sex differences in the prevalence and course of disease (18,19). In this study, we conducted a GWAS stratified by sex to investigate genetic factors associated with the endoscopically proven erosive esophagitis.

METHODS

Study subjects

We collected data from 10,349 individuals from the gene–environmental interaction and phenotype cohort, who visited the Seoul National University Hospital, Healthcare System Gangnam Center, for routine health checkups from 2014 to 2015. Detailed population characteristics and cohort protocols have been previously described (20). From the gene–environmental interaction and phenotype cohort, we retrospectively collected the data of 4,242 individuals aged 50 years and older who underwent upper gastrointestinal endoscopic examination for gastric cancer screening. We divided the enrolled population into 2 groups based on the time of enrollment. Samples donated between January 2014 and April 2015 comprised the discovery cohort (n = 3,620), and those enrolled between May 2015 and December 2015 comprised the replication cohort (n = 622).

Data collection and SNP analysis

All participants donated blood samples for DNA collection and genotyping after informed consent was obtained. Donated blood samples were stored at a biorepository, and genomic DNA was isolated. SNP genotyping was performed by hybridization on an Affymetrix Axiom KORV1.0-96 Array (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer's protocol. Genotype data were produced using K-CHIPs designed by the Center for Genome Science, Korea National Institute of Health, Korea (4845–301, 3000–3031). Genotyping was performed by DNA Link (Seoul, Korea).

Endoscopic findings

All upper gastrointestinal endoscopies were performed using a conventional white-light videoendoscope (GIF-H260 series endoscopes; Olympus Optical, Tokyo, Japan) by one of the 16 board-certified gastroenterologists. Erosive esophagitis, defined as mucosal breaks above the gastroesophageal junction, was diagnosed through endoscopy. The severity of erosive esophagitis was graded from A to D according to the Los Angeles (LA) classification with Japanese modifications (21). The accompanying findings, such as hiatal hernia, were recorded.

Quality control and statistical analysis

Quality control was performed using PLINK (version 1.07; Free Software Foundation, Boston, MA). We excluded samples with (i) sex inconsistencies, (ii) missing genotype call rate >3%, and (iii) related or cryptically related individuals (identical by descent >0.185). SNPs were excluded if they had (i) missing call rate >5%, (ii) minor allele frequency <1%, and (iii) P value of the Hardy-Weinberg equilibrium test <10−5. SHAPEIT2 v2.r837 and IMPUTE2 version 2.3.2 were used for data prephasing and genotype imputation. Data from the 1,000 Genomes phase 3 haplotypes were used as a reference panel. Imputed SNPs with info metric in IMPUTE2 below 0.5 were removed for this study. After quality control and imputation, a total of 3,693,205 SNPs were used for this GWAS.

For each SNP that passed all the filtering criteria, we conducted a disease association study separately in men and women using a multiple linear regression model while controlling for age. Comparisons of continuous variables were performed using the Student t test, and categorical variables were compared using a χ2 or the Fisher exact test. Analysis was performed using R statistical software package, version 3.1.1 (R Development Core Team; R Foundation for Statistical Computing, Vienna, Austria). SNPs with P < 5.0 × 10−8 were considered to be significant genome wide. To evaluate the combined effects of the significant SNPs on erosive esophagitis, we used the simple count method to calculate a genetic risk score in the discovery cohort. The results were considered statistically significant at a P value less than 0.05.

SNPs that had a P value less than 5.0 × 10−8 in the discovery set were re-evaluated for validation in the replication set. P values less than 0.05 were considered significant in the validation cohort.

Ethics statement

Approval was obtained from the Institutional Review Board (IRB) of the Seoul National University Hospital for the storage of biospecimens (IRB number 1103-127-357), which were used retrospectively. This study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and its subsequent revisions and was approved by the board (IRB number 1610-102-801).

RESULTS

Baseline characteristics

A total of 4,242 participants were included in this investigation. Among the enrolled subjects, erosive esophagitis was diagnosed in 748 participants (17.6%): 586 (78.3%) in grade LA-A, 145 (19.4%) in grade LA-B, and 17 (2.3%) in grade LA-C or D. The diagnosis of erosive esophagitis was much higher in male subjects (22.3%) than in female subjects (9.8%). The characteristics of the discovery and validation cohorts according to sex are summarized in Table 1. Based on the accompanying endoscopic findings, hiatal hernia and BE were observed in 78 (10.4%) and 30 (4.0%) patients with erosive esophagitis, respectively (Table 2). A quantile–quantile plot is shown in Supplementary Digital Content 1 (see Figure 1, https://links.lww.com/CTG/A220). There was no factor that was significantly different between the cases and controls in both the discovery and replication cohorts.

T1
Table 1.:
Baseline characteristics of the discovery and validation sets according to sex differences
T2
Table 2.:
Endoscopic finding and erosive esophagitis according to the Los Angeles classification (N = 4,242)

GWAS for erosive esophagitis

The GWAS was conducted using 3,693,205 SNPs to identify genetic factors associated with erosive esophagitis. Because the demographic characteristics in erosive esophagitis varied according to sex, we performed genetic analysis separately in men and women. In the discovery set, we detected 6 genome-wide significant SNPs associated with erosive esophagitis in men: rs518309 (P = 2.12 × 10−8), rs654455 (P = 2.12 × 10−8), rs562589 (P = 2.504 × 10−8), rs594589 (P = 2.786 × 10−8), rs513126 (P = 2.93 × 10−8), and rs4445064 (P = 5.864 × 10−8). These SNPs are clustered near the GRIK2 gene on chromosome 6. A regional plot for rs518309 is shown in Figure 1, and a Manhattan plot for the erosive esophagitis GWAS is shown in Supplementary Digital Content 2 (see Figure 2, https://links.lww.com/CTG/A221). We performed a validation test with a replication cohort, and all SNPs remained significant (P < 0.05) (Table 3). There were no significant SNPs found for female subjects.

F1
Figure 1.:
Regional plot for novel genome-wide significant single-nucleotide polymorphisms (SNPs) associated with erosive esophagitis in men. Associations of individual SNPs are plotted as −log10 P against the chromosomal position. The results of both genotyped and imputed SNPs are shown. Colors indicate the linkage disequilibrium strength between the most significant SNPs and the other SNPs assessed.
T3
Table 3.:
Logistic regression analysis results of the genome-wide association study for erosive esophagitis in male subjects

Prediction of erosive esophagitis

We selected the 6 genome-wide significant SNPs for a prediction model of erosive esophagitis in male subjects. Erosive esophagitis was categorized into 4 groups (normal, LA-A, LA-B, and LA-C or D). In the case–control model, relative risk for erosive esophagitis was 1.08 (95% confidence interval [CI] = 1.05–1.12, P < 0.0001), with the control as a reference. According to the LA classification, the relative risks for severe reflux esophagitis were 1.08 (95% CI = 1.05–1.12, P < 0.0001) in LA-A, 1.09 (95% CI = 1.03–1.15, P = 0.002) in LA-B, and 1.16 (95% CI = 1.01–1.34, P = 0.04) in LA-C or D, as shown in Figure 2.

F2
Figure 2.:
Prediction of erosive esophagitis risk in men using genetic scoring. Severity of reflux esophagitis is described by the LA classification: LA-A, LA-B, and LA-C or D. CI, confidence interval; LA, Los Angeles.

DISCUSSION

To the best of our knowledge, this is the first GWAS to have identified novel genome-wide significant SNPs associated with erosive esophagitis proven by endoscopy. We detected 6 SNPs near the glutamate ionotropic receptor kainate type subunit 2 (GRIK2) gene on chromosome 6 as a novel marker for erosive esophagitis in male participants, and this variation significantly predicted erosive esophagitis through the genetic risk score.

Although many studies have made an effort to find genetic factors associated with GERD, they have failed to identify any genome-wide significant loci, in contrast to those found for BE and EAC (22). Both erosive esophagitis and NERD belong to GERD, which is characterized by heartburn and regurgitation, but it has recently been suggested that the underlying mechanism of development of erosive esophagitis is different from that of NERD (23). Although upper gastrointestinal endoscopies are the gold standard for diagnosis and classification of erosive esophagitis, they are not widely used in the Western countries because of cost-effectiveness and invasiveness. In Korea, there is a high prevalence of gastric cancer, and a screening upper endoscopy is recommended for gastric cancer prevention. From the health checkup population, patients with erosive esophagitis found incidentally through upper endoscopy were included in this study. Thus, we could conduct the first GWAS for erosive esophagitis diagnosed by endoscopy, regardless of the GERD symptoms. In addition, we could evaluate the severity of erosive esophagitis and identify the relationship between the severity and genetic factors.

We found that genome-wide significant SNPs associated with erosive esophagitis only among male subjects. Similar to other studies, male subjects were found to have a 2-fold higher risk for erosive esophagitis compared with female subjects. Although being men is a powerful risk factor, erosive esophagitis is well known to be a multifactorial disease resulting from structural, environmental, hormonal, and genetic factors (2,10,11,24). Thus, we analyzed the baseline demographic data, including age, waist circumference, and smoking status. We found no significant differences in both our discovery and replication cohorts. Sex hormones could affect the prevalence and severity of GERD. In postmenopausal women, the prevalence of GERD rapidly increased, although it was lower than that in men in the reproductive period (25,26). In a recent study, rat models of erosive esophagitis showed male-predominant sex differences in esophageal damage through the protective effect of estrogen E2 receptor (27). This suggests that even if a female subject is at genetic risk for erosive esophagitis, she may also have a hormonal protective effect. This could help explain the significant genetic associations in male subjects only and elucidate the pathogenesis of erosive esophagitis.

The most genome-wide significant SNP (rs518309) is located 875 kb away from the GRIK2 gene on chromosome 6q16.3. We found 6 genome-wide significant SNPs located in the topological domain of the chromosomal rearranged region of the GRIK2 gene (3Disease Browser, http://3dgb.cbi.pku.edu.cn/disease/, http://promoter.bx.psu.edu/hi-c/view.php). The GRIK2 gene encodes the glutamate ionotropic receptor kainate type subunit 2 (GRIK2), a member of the glutamate receptor family (28). Glutamate receptors play a role in synaptic excitation in neuronal cells, and these glutamatergic synapses are also found in the vago-vagal neural pathway (29–31). Transient lower esophageal sphincter (LES) relaxation is an important mechanism of GERD and is regulated by the vago-vagal neural pathway. In a recent study, the metabotropic glutamate receptor 5 antagonist reduced gastroesophageal reflux episode by preventing transient LES relaxation and increasing LES pressure (32). We suggested that the GRIK2 gene might be related to the pathogenesis of erosive esophagitis through transient LES relaxation via glutamatergic synapse.

In this cohort, hiatal hernia was more common in patients with erosive esophagitis (10.4%) than in normal controls (1.0%). Although the relationship between hiatal hernia and GERD has been discussed over the past decades, hiatal hernias are quite common among patients with GERD and may result in structural imperfections that affect the LES function (33). Gastric distension can potently stimulate transient LES relaxation and induce anatomical vulnerabilities associated with hiatal hernia and predisposition to transient LES relaxation in patients with GERD (34). As mentioned above, erosive esophagitis is closely related to BE and EAC, but cases with BE were rare, and EAC was not observed in this study. This is likely because these 2 diseases are much rarer in Asians than in whites (35). Therefore, it is not presently possible to determine the relationship between the identified SNPs and these diseases.

Our study has several limitations. First, we selected the discovery and validation cohorts from the same population because this study was conducted by a single health screening center in Korea. As a result, the findings may not apply to individuals of other ethnic populations. Thus, a replication study should be conducted using a different population in the future. Second, we could not find significantly associated SNPs in female subjects. As mentioned previously, there may be a protective effect of estrogen affecting the development of erosive esophagitis in female subjects. In addition, the incidence of erosive esophagitis in women was low, and hence, a larger sample is needed for the study to have adequate statistical power. Third, these SNPs have not been previously reported in association with GERD, BE, and EAC. Because studies on these were mostly conducted in the Western populations, few have been conducted in Asian populations and so, these SNPs may not have been found to be significant because of ethnic differences. Finally, we were unable to examine GERD symptoms or a medication history because of the retrospective nature of the study.

In summary, we report the first GWAS of erosive esophagitis with 6 genome-wide significant SNPs in male subjects. These 6 SNPs near the GRIK2 gene could help explain the pathogenesis of erosive esophagitis and contribute to the understanding of sex differences. Further genetic investigation of erosive esophagitis could allow for the prediction of high risk for erosive esophagitis and development of new treatment options.

CONFLICTS OF INTEREST

Guarantor of the article: Sung-Ae Jung, MD, PhD.

Specific author contributions: Eun Hyo Jin, MD, PhD, and Boram Park, MPH, contributed equally to this work. S.-A.J.: concept development and conducting the study. E.H.J.: drafting the manuscript and interpreting the data. B.P.: performing statistical analysis. Y.S.K.: writing review and editing. E.K.C.: collecting data and contributing methodology. S.H.C.: investigation and data curation. J.S.K.: conceptualization. All authors: approval of the final manuscript.

Financial support: None to report.

Potential competing interests: None to report.

Study Highlights

WHAT IS KNOWN

  • ✓ Erosive esophagitis is diagnosed by endoscopy and shows male-predominant sex difference.
  • ✓ Genes affecting the susceptibility to erosive esophagitis have not yet been identified.

WHAT IS NEW HERE

  • ✓ This GWAS stratified by sex investigated genetic factors associated with erosive esophagitis.
  • ✓ Genome-wide significant SNPs associated with erosive esophagitis implicated GRIK2 in men and predicted severity.

TRANSLATIONAL IMPACT

  • ✓ These SNPs could help explain erosive esophagitis pathogenesis and inform the development of new therapies.

REFERENCES

1. Vakil N, van Zanten SV, Kahrilas P, et al. The montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006;101(8):1900–20; quiz 1943.
2. Shim KN, Hong SJ, Sung JK, et al. Clinical spectrum of reflux esophagitis among 25,536 Koreans who underwent a health check-up: A nationwide multicenter prospective, endoscopy-based study. J Clin Gastroenterol 2009;43(7):632–8.
3. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol 2005;40(3):275–85.
4. Ha NR, Lee HL, Lee OY, et al. Differences in clinical characteristics between patients with non-erosive reflux disease and erosive esophagitis in Korea. J Korean Med Sci 2010;25(9):1318–22.
5. Spechler SJ, Souza RF. Barrett's esophagus. N Engl J Med 2014;371(9):836–45.
6. Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 2005;162(11):1050–61.
7. Nusrat S, Nusrat S, Bielefeldt K. Reflux and sex: What drives testing, what drives treatment? Eur J Gastroenterol Hepatol 2012;24(3):233–47.
8. Kim YS, Kim N, Kim GH. Sex and gender differences in gastroesophageal reflux disease. J Neurogastroenterol Motil 2016;22(4):575–88.
9. Ford AC, Forman D, Reynolds PD, et al. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol 2005;162(5):454–60.
10. Nilsson M, Johnsen R, Ye W, et al. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 2004;39(11):1040–5.
11. Adachi K, Mishiro T, Tanaka S, et al. Gender differences in the time-course changes of reflux esophagitis in Japanese patients. Intern Med 2015;54(8):869–73.
12. Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in gastro-oesophageal reflux disease: A twin study. Gut 2003;52(8):1085–9.
13. Post JC, Ze F, Ehrlich GD. Genetics of pediatric gastroesophageal reflux. Curr Opin Allergy Clin Immunol 2005;5(1):5–9.
14. Gharahkhani P, Tung J, Hinds D, et al. Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus. Hum Mol Genet 2016;25(4):828–35.
15. Su Z, Gay LJ, Strange A, et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet 2012;44(10):1131–6.
16. Palles C, Chegwidden L, Li X, et al. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterology 2015;148(2):367–78.
17. Gharahkhani P, Fitzgerald RC, Vaughan TL, et al. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: A large-scale meta-analysis. Lancet Oncol 2016;17(10):1363–73.
18. Aragam N, Wang KS, Pan Y. Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples. J Affect Disord 2011;133(3):516–21.
19. Randall JC, Winkler TW, Kutalik Z, et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013;9(6):e1003500.
20. Lee C, Choe EK, Choi JM, et al. Health and prevention enhancement (H-PEACE): A retrospective, population-based cohort study conducted at the Seoul National University Hospital Gangnam Center, Korea. BMJ Open 2018;8(4):e019327.
21. Miwa H, Yokoyama T, Hori K, et al. Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles classification incorporating grades N and M: A validation study in a cohort of Japanese endoscopists. Dis Esophagus 2008;21(4):355–63.
22. Ek WE, Levine DM, D'Amato M, et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst 2013;105(22):1711–8.
23. Hershcovici T, Fass R. Nonerosive reflux disease (NERD)—An update. J Neurogastroenterol Motil 2010;16(1):8–21.
24. Chung SJ, Kim D, Park MJ, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: A cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008;57(10):1360–5.
25. Menon S, Jayasena H, Nightingale P, et al. Influence of age and sex on endoscopic findings of gastrooesophageal reflux disease: An endoscopy database study. Eur J Gastroenterol Hepatol 2011;23(5):389–95.
26. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: Prospective evaluation by endoscopy. J Gastroenterol 1999;34(4):441–4.
27. Masaka T, Iijima K, Endo H, et al. Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats. Gut 2013;62(1):6–14.
28. Wu CS, Lu YJ, Li HP, et al. Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer 2010;126(11):2542–52.
29. Brassai A, Suvanjeiev RG, Ban EG, et al. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity. Brain Res Bull 2015;112:1–6.
30. Browning KN, Travagli RA. Plasticity of vagal brainstem circuits in the control of gastric function. Neurogastroenterol Motil 2010;22(11):1154–63.
31. Tack J, Pandolfino JE. Pathophysiology of gastroesophageal reflux disease. Gastroenterology 2018;154(2):277–88.
32. Rouzade-Dominguez ML, Pezous N, David OJ, et al. The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease. Neurogastroenterol Motil 2017;29(8).
33. Hyun JJ, Bak YT. Clinical significance of hiatal hernia. Gut Liver 2011;5(3):267–77.
34. Kahrilas PJ, Shi G, Manka M, et al. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology 2000;118(4):688–95.
35. Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: An update focusing on refractory reflux disease and Barrett's oesophagus. Gut 2016;65(9):1402–15.

Supplemental Digital Content

© 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology